IRCT20230125057216N1CompletedPhase 2
Evaluating the effect of curcumex supplement on the symptoms of patients with COVID-19
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 years to 60 years (—)
- Sex
- All
Inclusion Criteria
- •ground glass opacity in lung CT scan
- •Clinical symptoms such as dry cough- dyspnea-fever- weakness- diarrhea- headache-rhinorrhea- or history of contact with COVID19 patient or recent travel to high-risk areas
- •Positive Covid-19PCR
Exclusion Criteria
- •PO intolerance
- •Dissatisfaction for Participation in research
Investigators
Similar Trials
Recruiting
Phase 3
the effect of curcumin supplementation on depression, anxiety, pain and BDNF serum concentration in patients with gastrointestinal cancerGastrointestinal Malignancy.Malignant neoplasm of ill-defined sites within the digestive systemC26.9IRCT20240521061860N1Zahedan University of Medical Sciences64
Recruiting
Unknown
Curcumin and the gut microbiota alterationsObesity and weight gain.Overweight and obesityIRCT20240209060948N1Islamic Azad University80
Recruiting
Phase 2
The effect of Curcumin supplementation on mortality rate and clinical status in patients with traumaIRCT20130829014521N21Mashhad University of Medical Sciences327
Recruiting
Phase 3
Curcumin supplementation in cancer patients under cisplatin treatmentCancer types.Malignant neoplasm of ovary, Malignant neoplasm of breastC56, C50IRCT20190305042939N2Esfahan University of Medical Sciences50
Recruiting
Phase 3
The effect of Curcumin on Polycystic Ovary Syndrome.IRCT20180503039511N1Esfahan University of Medical Sciences60